合計 50 件の最近のインサイダー取引記録が記録されています Dyne Therapeutics, Inc. (DYN), 内訳は 20 件の買い および 26 件の売り. インサイダー買い総額は $18.34M インサイダー売り総額は $11.85M.
最近活動のある主要インサイダーには Lucera Erick, Posner Brian S, Kersten Dirk. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — DYN
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-04-01 |
Lucera Erick |
Chief Financial Officer |
情報に基づく売り |
5,727 |
$18.64 |
$106.75K |
125,373 |
| 2026-03-30 |
Posner Brian S |
Director |
情報に基づく買い |
2,000 |
$17.08 |
$34.16K |
15,500 |
| 2026-03-11 |
Posner Brian S |
Director |
情報に基づく買い |
2,000 |
$19.35 |
$38.7K |
13,500 |
| 2026-03-11 |
Kersten Dirk |
Director |
情報に基づく売り |
129,672 |
$19.52 |
$2.53M |
4,644,386 |
| 2026-03-10 |
Kersten Dirk |
Director |
情報に基づく売り |
281,858 |
$19.80 |
$5.58M |
4,774,058 |
| 2026-03-09 |
Kersten Dirk |
Director |
情報に基づく売り |
177,690 |
$17.72 |
$3.15M |
5,285,156 |
| 2026-03-06 |
Posner Brian S |
Director |
情報に基づく買い |
3,000 |
$15.06 |
$45.18K |
11,500 |
| 2026-03-05 |
Cox John |
CEO & President |
情報に基づく売り |
2,732 |
$14.90 |
$40.71K |
374,145 |
| 2026-03-05 |
Kerr Douglas |
Chief Medical Officer |
情報に基づく売り |
904 |
$14.90 |
$13.47K |
171,606 |
| 2026-03-05 |
Friedl-naderer Johanna |
Chief Commercial Officer |
情報に基づく売り |
148 |
$14.90 |
$2.21K |
154,581 |
| 2026-02-12 |
Cox John |
CEO & President |
RSU 付与（制限付株式） |
285,000 |
$16.00 |
$4.56M |
285,000 |
| 2026-02-12 |
Lucera Erick |
Chief Financial Officer |
RSU 付与（制限付株式） |
105,000 |
$16.00 |
$1.68M |
105,000 |
| 2026-02-12 |
Kerr Douglas |
Chief Medical Officer |
RSU 付与（制限付株式） |
130,000 |
$16.00 |
$2.08M |
130,000 |
| 2026-02-12 |
Friedl-naderer Johanna |
Chief Commercial Officer |
RSU 付与（制限付株式） |
90,000 |
$16.00 |
$1.44M |
90,000 |
| 2025-12-22 |
Karnani Vikram |
Officer |
不明 |
- |
- |
- |
- |
| 2025-12-22 |
Karnani Vikram |
Director |
RSU 付与（制限付株式） |
59,665 |
$20.78 |
$1.24M |
59,665 |
| 2025-12-05 |
Cox John |
CEO & President |
情報に基づく売り |
2,662 |
$20.72 |
$55.16K |
196,877 |
| 2025-12-05 |
Kerr Douglas |
Chief Medical Officer |
情報に基づく売り |
880 |
$20.72 |
$18.23K |
87,510 |
| 2025-12-05 |
Friedl-naderer Johanna |
Chief Commercial Officer |
情報に基づく売り |
144 |
$20.72 |
$2.98K |
94,729 |
| 2025-10-01 |
Posner Brian S |
Director |
不明 |
- |
- |
- |
8,500 |
| 2025-10-01 |
Posner Brian S |
Director |
RSU 付与（制限付株式） |
70,000 |
$12.50 |
$875K |
70,000 |
| 2025-09-05 |
Kerr Douglas |
Chief Medical Officer |
情報に基づく売り |
873 |
$13.41 |
$11.71K |
88,390 |
| 2025-09-05 |
Friedl-naderer Johanna |
Chief Commercial Officer |
情報に基づく売り |
144 |
$13.41 |
$1.93K |
94,873 |
| 2025-09-05 |
Cox John |
CEO & President |
情報に基づく売り |
2,640 |
$13.41 |
$35.4K |
199,539 |
| 2025-09-04 |
Kerr Douglas |
Chief Medical Officer |
情報に基づく売り |
3,552 |
$13.27 |
$47.14K |
89,263 |
| 2025-09-04 |
Friedl-naderer Johanna |
Chief Commercial Officer |
情報に基づく売り |
894 |
$13.27 |
$11.86K |
95,017 |
| 2025-07-16 |
Cox John |
CEO & President |
RSU 付与（制限付株式） |
197,285 |
$9.33 |
$1.84M |
197,285 |
| 2025-07-16 |
Kerr Douglas |
Chief Medical Officer |
RSU 付与（制限付株式） |
65,110 |
$9.33 |
$607.48K |
65,110 |
| 2025-07-16 |
Friedl-naderer Johanna |
Chief Commercial Officer |
RSU 付与（制限付株式） |
51,255 |
$9.33 |
$478.21K |
51,255 |
| 2025-07-15 |
Cox John |
CEO & President |
贈与（送付） |
10,000 |
- |
- |
202,179 |
| 2025-07-14 |
Cox John |
CEO & President |
情報に基づく買い |
100,000 |
$9.11 |
$911K |
242,179 |
| 2025-06-05 |
Cox John |
CEO & President |
情報に基づく売り |
4,060 |
$13.35 |
$54.2K |
142,179 |
| 2025-06-05 |
Kerr Douglas |
Chief Medical Officer |
情報に基づく売り |
1,342 |
$13.35 |
$17.92K |
92,815 |
| 2025-06-05 |
Friedl-naderer Johanna |
Chief Commercial Officer |
情報に基づく売り |
146 |
$13.35 |
$1.95K |
95,911 |
| 2025-05-30 |
Hurwitz Edward |
Director |
RSU 付与（制限付株式） |
35,000 |
$11.96 |
$418.6K |
35,000 |
| 2025-05-30 |
Lubner David Charles |
Director |
RSU 付与（制限付株式） |
35,000 |
$11.96 |
$418.6K |
35,000 |
| 2025-05-30 |
Rhodes Jason P |
Director |
RSU 付与（制限付株式） |
35,000 |
$11.96 |
$418.6K |
35,000 |
| 2025-05-30 |
Stehman-breen Catherine |
Director |
RSU 付与（制限付株式） |
35,000 |
$11.96 |
$418.6K |
35,000 |
| 2025-05-30 |
Kersten Dirk |
Director |
RSU 付与（制限付株式） |
35,000 |
$11.96 |
$418.6K |
35,000 |
| 2025-05-30 |
Incerti Carlo |
Director |
RSU 付与（制限付株式） |
35,000 |
$11.96 |
$418.6K |
35,000 |
| 2025-03-31 |
Lucera Erick |
Officer |
不明 |
- |
- |
- |
- |
| 2025-03-31 |
Lucera Erick |
Chief Financial Officer |
RSU 付与（制限付株式） |
66,100 |
- |
- |
66,100 |
| 2025-03-13 |
Friedl-naderer Johanna |
Chief Commercial Officer |
情報に基づく売り |
143 |
$12.12 |
$1.73K |
96,057 |
| 2025-03-11 |
Scalzo Richard William |
SVP, Head of Finance & Admin. |
情報に基づく売り |
1,343 |
$11.38 |
$15.28K |
122,330 |
| 2025-03-11 |
Beskrovnaya Oxana |
Chief Scientific Officer |
情報に基づく売り |
2,153 |
$11.38 |
$24.5K |
195,840 |
| 2025-03-05 |
Cox John |
CEO & President |
情報に基づく売り |
4,061 |
$11.83 |
$48.04K |
146,239 |
| 2025-03-05 |
Scalzo Richard William |
SVP, Head of Finance & Admin. |
情報に基づく売り |
917 |
$11.83 |
$10.85K |
123,673 |
| 2025-03-05 |
Kerr Douglas |
Chief Medical Officer |
情報に基づく売り |
1,343 |
$11.83 |
$15.89K |
94,157 |
| 2025-03-05 |
Beskrovnaya Oxana |
Chief Scientific Officer |
情報に基づく売り |
1,094 |
$11.83 |
$12.94K |
197,993 |
| 2025-02-18 |
Scalzo Richard William |
SVP, Head of Finance & Admin. |
情報に基づく売り |
2,488 |
$13.95 |
$34.71K |
124,590 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
